Home

Joseph Talamo

CIK 1524547 · Chief Financial Officer · last filed 2026-07-20

Joseph Talamo is a Chief Financial Officer who has filed 32 SEC Form 4 insider transactions across 4 companies since 2011. The most recent filing, for INTS, was dated Jul 20, 2026. Current disclosed insider exposure totals $10.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.2K

Companies

4

Total Filings

32

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
INTS Chief Financial Officer 2,239 $4.55 $10.2K $0 7 2026-07-20
LISATA THERAPEUTICS, INC. (CLBS) Delisted SVP and CFO 3,976 $6.40 $25.4K $0 17 2020-01-15
LISATA THERAPEUTICS, INC. (NBS) Delisted Chief Accounting Officer 30,839 — — $0 6 2015-06-04
LISATA THERAPEUTICS, INC. (NBS.WS) Delisted See Remarks — — — $0 2 2012-01-06

Recent Filings

32 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-20 INTS Grant (A) — $0 EDGAR
2026-07-01 INTS Grant (A) +1,093 $3.8K EDGAR
2026-01-05 INTS Grant (A) +14,482 $3.8K EDGAR
2025-07-02 INTS Grant (A) +14,179 $3.7K EDGAR
2025-05-06 INTS Grant (A) — $0 EDGAR
2024-10-23 INTS Grant (A) — $0 EDGAR
2023-12-12 INTS Grant (A) — $0 EDGAR
2020-01-15 LISATA THERAPEUTICS, INC. (CLBS) Delisted Mixed +14,209 -$15.9K EDGAR
2020-01-09 LISATA THERAPEUTICS, INC. (CLBS) Delisted Tax (F) −1,821 -$5.2K EDGAR
2019-01-16 LISATA THERAPEUTICS, INC. (CLBS) Delisted Mixed +13,841 $0 EDGAR
Showing 1–10 of 32
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.